ARK Innovation ETF ARKK TXMD TherapeuticsMD shares gain 58 percent despite wider than expected Q3 2023 per share loss FTV Fortive Corporation beats Q1 earnings estimates by 8 posting EPS of 070 vs 065 forecast Consolidated Edison ED Core Defensive Dividend Pick for Retirement Portfolios Amid FixedIncome Yield Headwinds Trainline Lifts Guidance Again Signaling Strong Momentum Microsoft Earnings Beat Fails to Lift Share Price Market Sentiment Remains Cautious Microsoft and Anthropic in Talks for Custom AI Chip Supply Amid 5 Billion Investment Nvidia Stock Dips PostEarnings Why Market Skeptics May Be Overlooking Key Fundamentals Iran Standoff Intensifies as Trump Rejects Counteroffer Strait of Hormuz Disruption Threatens Global Energy Markets HCW Biologics Inc HCWB Q1 2026 Earnings Strong EPS Surprise Drives DoubleDigit Stock Rally PDSB Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Progress Continues ATT Q1 2026 Earnings EPS Slightly Beats Estimates Stock Edges Lower CMI Q1 2026 Earnings EPS Beat of 897 Surprises Analysts CZR Q1 2026 Earnings WiderthanExpected Loss Weighs on Sentiment Silicon Laboratories Inc SLAB Edges Higher Amid Sector Rotation Key Levels in Focus Hawkins Inc HWKN Edges Higher as Support Holds Near 145 NetSTREIT NTST Edges Lower as Consolidation Continues Near Key Support Dolphin Entertainment DLPN Slides 4 as Stock Approaches Key Support at 112 CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain HF Foods Group HFFG Drops 39 as Stock Nears Key Support at 185 Universal Music Group Board Rejects Bill Ackmans 65 Billion Takeover Bid as Undervaluing the Company APPN Q1 2026 Earnings EPS Surges Past Estimates Stock Rallies Williams Companies Sees Renewed Analyst Interest Amid Natural Gas Infrastructure Demand Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates but Stock Gains Dominos Pizza DPZ Hovers Near Support as Consolidation Continues Solid Power SLDP Struggles as Shares Dip Below 340 Inhibrx Biosciences INBX Slips 2 as Stock Tests Key Support Amid Biotech Volatility Stereotaxis Inc STXS Slips 48 Testing Key Support at 188 Genasys Inc GNSS Edges Higher at 213 Testing Resistance Zone Near 224 ClearThink 1 Acquisition Corp Units CTAAU Holds Steady at 1006 Amid Consolidation Phase Hovnanian Preferred Stock HOVNP Holds Steady Near Support as Volume Remains Measured Haoxi Health Technology HAO Slides to 099 Tests Key Support Level